Zhi Zhong

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Acute Myocardial Infarction

High Fat Diet Induced

Histone Deacetylase

Top Venues

RPS pharmacy and pharmacology reports

Alcoholism, clinical and experimental research

This page only lists publications with an associated author ORCID identifier.

Publications

Devadoss J Samuvel, Yasodha Krishnasamy, Li Li, John J Lemasters, C James Chou, Zhi Zhong
LP342, a novel histone deacetylase inhibitor, decreases nitro-oxidative stress, mitochondrial dysfunction and hepatic ischaemia/reperfusion injury in mice. RPS pharmacy and pharmacology reports 2 (2) (2023)
Devadoss J Samuvel, Yasodha Krishnasamy, Li Li, John J Lemasters, C James Chou, Zhi Zhong
LP342, a novel histone deacetylase inhibitor, decreases nitro-oxidative stress, mitochondrial dysfunction and hepatic ischaemia/reperfusion injury in mice. RPS pharmacy and pharmacology reports 2 (2) (2023)
Devadoss J Samuvel, Yasodha Krishnasamy, Li Li, John J Lemasters, C James Chou, Zhi Zhong
LP342, a novel histone deacetylase inhibitor, decreases nitro-oxidative stress, mitochondrial dysfunction and hepatic ischaemia/reperfusion injury in mice. RPS pharmacy and pharmacology reports 2 (2) (2023)
Devadoss J Samuvel, Yasodha Krishnasamy, Li Li, John J Lemasters, C James Chou, Zhi Zhong
LP342, a novel histone deacetylase inhibitor, decreases nitro-oxidative stress, mitochondrial dysfunction and hepatic ischaemia/reperfusion injury in mice. RPS pharmacy and pharmacology reports 2 (2) (2023)
Zhi Zhong, John J Lemasters
A Unifying Hypothesis Linking Hepatic Adaptations for Ethanol Metabolism to the Proinflammatory and Profibrotic Events of Alcoholic Liver Disease. Alcoholism, clinical and experimental research 42 (11) (2018)